Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+20.3%
5Y CAGR+17.9%
Year-over-Year Change
Research and development spending
3Y CAGR
+20.3%/yr
vs +160.2%/yr prior
5Y CAGR
+17.9%/yr
Consistent
Acceleration
-139.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $186.18M | +32.4% |
| 2024 | $140.63M | +37.1% |
| 2023 | $102.61M | -4.0% |
| 2022 | $106.84M | -18.7% |
| 2021 | $131.43M | +61.1% |
| 2020 | $81.61M | +89.8% |
| 2019 | $42.99M | +1744.3% |
| 2018 | $2.33M | - |